Your browser doesn't support javascript.
loading
Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease.
Ding, Qiao; Kesavan, Kaamini; Lee, Kah Meng; Wimberger, Elyse; Robertson, Thomas; Gill, Melinder; Power, Dominique; Chang, Jeryn; Fard, Atefeh T; Mar, Jessica C; Henderson, Robert D; Heggie, Susan; McCombe, Pamela A; Jeffree, Rosalind L; Colditz, Michael J; Hilliard, Massimo A; Ng, Dominic C H; Steyn, Frederik J; Phillips, William D; Wolvetang, Ernst J; Ngo, Shyuan T; Noakes, Peter G.
Afiliação
  • Ding Q; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Kesavan K; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Lee KM; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Wimberger E; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Robertson T; Pathology Queensland, Faculty of Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, 4006, Australia.
  • Gill M; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Power D; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Chang J; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Fard AT; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Mar JC; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Henderson RD; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Heggie S; Department of Neurology, Royal Brisbane and Women's Hospital, 4006, Herston, QLD, Australia.
  • McCombe PA; University of Queensland Centre for Clinical Research, The University of Queensland, Herston, QLD, 4006, Australia.
  • Jeffree RL; Department of Neurology, Royal Brisbane and Women's Hospital, 4006, Herston, QLD, Australia.
  • Colditz MJ; Department of Neurology, Royal Brisbane and Women's Hospital, 4006, Herston, QLD, Australia.
  • Hilliard MA; University of Queensland Centre for Clinical Research, The University of Queensland, Herston, QLD, 4006, Australia.
  • Ng DCH; Department of Neurosurgery, Royal Brisbane and Women's Hospital, Herston, QLD, 4006, Australia.
  • Steyn FJ; Department of Neurosurgery, Royal Brisbane and Women's Hospital, Herston, QLD, 4006, Australia.
  • Phillips WD; Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Wolvetang EJ; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Ngo ST; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
  • Noakes PG; Department of Neurology, Royal Brisbane and Women's Hospital, 4006, Herston, QLD, Australia.
Acta Neuropathol Commun ; 10(1): 61, 2022 04 25.
Article em En | MEDLINE | ID: mdl-35468848
ABSTRACT
A central event in the pathogenesis of motor neuron disease (MND) is the loss of neuromuscular junctions (NMJs), yet the mechanisms that lead to this event in MND remain to be fully elucidated. Maintenance of the NMJ relies upon neural agrin (n-agrin) which, when released from the nerve terminal, activates the postsynaptic Muscle Specific Kinase (MuSK) signaling complex to stabilize clusters of acetylcholine receptors. Here, we report that muscle from MND patients has an increased proportion of slow fibers and muscle fibers with smaller diameter. Muscle cells cultured from MND biopsies failed to form large clusters of acetylcholine receptors in response to either non-MND human motor axons or n-agrin. Furthermore, levels of expression of MuSK, and MuSK-complex components LRP4, Caveolin-3, and Dok7 differed between muscle cells cultured from MND patients compared to those from non-MND controls. To our knowledge, this is the first time a fault in the n-agrin-LRP4-MuSK signaling pathway has been identified in muscle from MND patients. Our results highlight the n-agrin-LRP4-MuSK signaling pathway as a potential therapeutic target to prolong muscle function in MND.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença dos Neurônios Motores / Agrina Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença dos Neurônios Motores / Agrina Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article